A whole-body MRI has been mostly a boutique experience. Fitnescity Health, which calls itself the largest US network of ...

New data covers the Wegovy pill in real life, an investigational drug at lower doses, and children as young as six.

Formerly Kesmalea, the London company says its degraders cross the blood-brain barrier in pieces, then self-assemble on the other side.

TimeWarp Longevity Protocol combines 25 compounds, a monthly senolytic reset and an app – one system built around the 2025 hallmarks update.

GSK and Alamar will profile more than 60,000 serum samples to see how one diagnosis can hide several diseases.

From brain scans to Super Mario, NeuroAge and TruDiagnostic explain how Younger turns personal health goals into public ...

Built with David Sinclair for Grok Bot, the free multi-agent system turns personal health data into checkable N-of-1 experiments.

Eisai’s CTAD slate includes five-year Clarity AD data, a real-world symposium and a look at lecanemab and donanemab dosing.

SIR2501, a SARM1 blocker with FDA Fast Track status for chemo nerve damage, gets three poster slots in Washington.

Employers get one platform for GLP-1 access, hormone therapy and chronic disease coaching, with clinicians still signing off ...

A new review argues that aging has several brakes, not one, and that the way genes are switched may hit the limit first.

A Frontiers in Aging perspective pitches encapsulated cells as a steady source of the antiaging protein, framed as a proposed ...